Beyond Compliance: Why the FDA’s 2026 Human Foods Program Priorities Signal a New Era for Food Safety Testing
In January 2026, the U.S. Food and Drug Administration (FDA) released the Human Foods Program (HFP) 2026 Priority Deliverables, unveiling
Talc, Asbestos, and Trust: Why Raw Material Testing Is Becoming Non-Negotiable in Cosmetics and Personal Care
For decades, talc has been one of the most widely used ingredients in cosmetics and personal care products. It improves
Medical Device Regulation in the U.S.: Why Compliance Is No Longer a Department — It’s a Business Strategy
For medical device manufacturers, the U.S. regulatory environment has never been simple. But in recent years, it has become something
The Patchwork Problem: How Fragmented State Food Chemical Laws Are Reshaping Compliance—and What Brands Must Do to Keep Up
For decades, food manufacturers in the U.S. could largely operate under a single assumption: if a product met federal standards,
When the Supply Chain Becomes a Patient Safety Risk: Why Medical Device Makers Must Rethink Resilience—Especially for Children
For most medical device companies, “supply chain” used to mean cost, lead time, and availability. If parts arrived on schedule
When “Forever Chemicals” Meet Finite Budgets: How Municipalities Can Defend Public Water with Credible PFAS Data
For decades, municipal water systems were judged on reliability, capacity, and cost. If the water flowed and met traditional chemical
